Leading companies and knowledge agents in health R & D & I, manufacturing and knowledge generators
New specialised training programmes with the participation of 15 companies
Submitted competitive projects
Activities with nearly 1,000 attendees
55% of member companies and institutions in health entrepreneurship
100% representation in the territory and representation of the transversality in the health sector
17 April 2024
Mowoot, member of CataloniaBio & HealthTech, launched a project in collaboration with Eurecat, also members, and the Jordi Gol i Gurina Primary Care Research Foundation to develop a device that becomes the first effective therapy for the treatment of IBS.
17 April 2024
Medichem, member of CataloniaBio & HealthTech, is pleased to announce the appointment of Pablo Álvarez as its new Chief Executive Officer (CEO). With an excellent track record in the pharmaceutical industry and a commitment to lead Medichem into a new phase of growth and success.
17 April 2024
The Josep Carreras Leukaemia Research Institute, member of CataloniaBio & HealthTech, opens a new lab with the incorporation of Dr. Vincenzo Calvanese, a consolidated researcher on stem cell biology. The new group will try to understand which molecular features and regulatory processes identify a blood stem cell, a fundamental knowledge to advance in many areas, like haematopoietic stem cell transplant, one of the few successful clinical applications of stem cells today.
16 April 2024
Ship2B Ventures, member of CataloniaBio & HealthTech, is driving 10 pioneering impact startups in the healthcare field through the BSocial Impact Fund, supported by Banc Sabadell, the European Investment Fund and Axis.
16 April 2024
Oncoheroes Biosciences, member of CataloniaBio & HealthTech, announce a significant milestone in its mission to combat pediatric brain cancer. In a recent paper published in SLAS Discovery journal titled "Development of a High-Throughput Screening Platform to Identify New Therapeutic Agents for Medulloblastoma Group 3" authored by Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, Berta Marti-Fuster, Cesare Spadoni, Darell D Bigner, and Eva Méndez, their team reveals the development of an innovative screening platform aimed at identifying potential drug candidates for medulloblastoma, a type of brain cancer prevalent in children
16 April 2024
Croda Pharma, member of CataloniaBio & HealthTech, has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived squalene for the vaccine industry.
16 April 2024
Reig Jofre, member of CataloniaBio & HealthTech, announces an investment of 5.8 million euros in the biotechnological company Leanbio, also a member. This investment aims at vertical integration in the development, characterization, and production of biotechnological-based active ingredients.
16 April 2024
Some of the member companies of CataloniaBio & HealthTech have been recognised by the 500 startups that are revolutionising the healthcare sector.
3 April 2024
The Catalan biotechnology company GoodGut, part of the HIPRA group and a member of CataloniaBio & HealthTech, has developed a solution to improve the detection of alterations in the intestinal microbiota. It has published the results of a clinical study demonstrating that the use of its test in colorectal cancer screening reduces false positives by 20%. This would contribute to a better optimization of the available resources in the healthcare system, as it would reduce the number of unnecessary colonoscopies and avoid the discomfort of undergoing this procedure if it is not strictly necessary.
3 April 2024
The Josep Carreras Institute (IJC), member of CataloniaBio & HealthTech, has received the provisional resolution of accreditation as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities. The IJC is one of the 10 institutions that have received accreditation in the 2023 call, placing it among the best research centers in the country based on excellence, scientific contributions, talent attraction capacity, and economic and social impact, among others.
Keep up to date with the latest news from CataloniaBio & HealthTech! News, Activities, Events ... Join now!!